Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial.
de Vlam K, Maksymowych WP, Gallo G, Rahman P, Mease P, Krishnan V, McVeigh CJ, Lisse J, Zhu D, Bolce RJ, Conaghan PG. de Vlam K, et al. Among authors: lisse j. Rheumatol Ther. 2024 Jun;11(3):691-707. doi: 10.1007/s40744-024-00660-7. Epub 2024 Apr 18. Rheumatol Ther. 2024. PMID: 38637464 Free PMC article.
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP, Baraliakos X, Lambert RG, Landewé R, Sandoval D, Carlier H, Lisse J, Li X, Hojnik M, Østergaard M. Maksymowych WP, et al. Among authors: lisse j. Lancet Rheumatol. 2022 Sep;4(9):e626-e634. doi: 10.1016/S2665-9913(22)00185-0. Epub 2022 Aug 9. Lancet Rheumatol. 2022. PMID: 38288892 Clinical Trial.
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.
McGonagle D, Kavanaugh A, McInnes IB, Kristensen LE, Merola JF, Strober B, Bolce R, Lisse J, Pustizzi J, Sapin C, Ritchlin C. McGonagle D, et al. Among authors: lisse j. Rheumatology (Oxford). 2024 Feb 10:keae060. doi: 10.1093/rheumatology/keae060. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38341669
Wrist Injuries in Climbers.
Schöffl V, von Schroeder H, Lisse J, El-Sheikh Y, Küpper T, Klinder A, Lutter C. Schöffl V, et al. Among authors: lisse j. Am J Sports Med. 2023 Nov;51(13):3416-3425. doi: 10.1177/03635465231199671. Epub 2023 Oct 6. Am J Sports Med. 2023. PMID: 37800447
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Landewé RBM, Poddubnyy D, Rahman P, Van den Bosch FE, Bolce R, Liu Leage S, Lisse JR, Park SY, Gensler L. Landewé RBM, et al. Among authors: lisse jr. Ann Rheum Dis. 2023 Feb;82(2):212-216. doi: 10.1136/ard-2022-222731. Epub 2022 Sep 13. Ann Rheum Dis. 2023. PMID: 36100350 Free PMC article. Clinical Trial.
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA.
Hunter T, Grabner M, Birt J, Isenberg K, Shan M, Teng CC, Wu J, Griffing K, Lisse J, Curtis JR. Hunter T, et al. Among authors: lisse j. Clin Rheumatol. 2022 Sep;41(9):2863-2874. doi: 10.1007/s10067-022-06230-y. Epub 2022 Jun 7. Clin Rheumatol. 2022. PMID: 35672618
92 results